ATLANTIS ABUTMENT FOR ZIMMER INTERFACE

K053450 · Atlantis Components, Inc. · NHA · Mar 3, 2006 · Dental

Device Facts

Record IDK053450
Device NameATLANTIS ABUTMENT FOR ZIMMER INTERFACE
ApplicantAtlantis Components, Inc.
Product CodeNHA · Dental
Decision DateMar 3, 2006
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3630
Device ClassClass 2

Intended Use

The Atlantis Abutment is intended for use as an accessory to an endosseous implant to support a prosthetic device in a partially or completely edentulous patient. It is intended for use to support single and multiple tooth prosthesis, in the mandible or maxilla. The prosthesis can be cement retained to the abutment. The abutment screw is intended to secure the abutment to the endosseous implant.

Device Story

Atlantis Abutment in Zirconia serves as accessory to endosseous dental implants; provides support for cement-retained prosthetic restorations. Device consists of yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) abutment and titanium alloy (Ti-6Al-4V ELI) screw. Used by dental professionals in clinical settings to restore function in partially or completely edentulous patients. Abutment secures to implant via screw; provides interface for prosthetic crown/bridge. Compatible with various implant systems including Zimmer Dental, Nobel Biocare, 3i, Lifecore, Sterngold, Implamed, Innova, and BioHorizons. May be used in early load scenarios depending on specific implant system protocol.

Clinical Evidence

No clinical data provided; substantial equivalence supported by design and material characteristics.

Technological Characteristics

Abutment material: Yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) per ISO 6872 & 13356. Abutment screw material: Titanium grade Ti-6Al-4V ELI per ASTM F-136. Mechanical interface for endosseous dental implants.

Indications for Use

Indicated for partially or completely edentulous patients requiring single or multiple tooth prosthetic support in the mandible or maxilla via cement-retained restorations on endosseous dental implants.

Regulatory Classification

Identification

An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ MAR 3 2006 Pre-market Notification Page - 0000009 --------------------------- # Kos 3450 ## VII. SECTION 10 - 510(K) SUMMARY This summary of 510(k) substantial equivalence information is being submitted in accordance with the requirements of 21 CFR Part 807.92. #### I . Applicant's Name and Address Atlantis Components Inc. 25 First Street Cambridge, Massachusetts 02141 Telephone Number: 617-661-9799 Fax Number: 617-661-9063 Contact Person: Franklin Uyleman Manager of Quality and Regulatory Affairs #### 2. Name of Device | Trade Name: | AtlantisTM Abutment in Zirconia | |----------------------|------------------------------------| | Common Name: | Endosseous dental implant abutment | | Classification Name: | Endosseous dental implant abutment | | | 21 CFR 872.3630 Product code NHA | #### 3. Legally Marketed Device to which Equivalence is claimed (Predicate Device) | Manufacturer | Device | 510(k) Number | |-----------------------------|-------------------------------|---------------| | Zimmer Dental | Screw Vent Implant System | K011028 | | Atlantis Components<br>Inc. | Atlantis Abutment in Zirconia | K052070 | #### 4. Description of the Device The devices covered in this submission are abutments which are placed into the dental implant to provide support for a prosthetic restoration. The subject abutments are indicated for cemented restorations. {1}------------------------------------------------ Pre-market Page - 000010 - - - - - - - - - - - - - - - - #### ধ Description of the Device (continued) The Atlantis™ Abutment in Zirconia is made of the biocompatible material, yttriastabilized tetragonal zirconia polycrystals (Y-TZP) (Meets ISO standards 6872 & 13356) and the abutment screw is made from Titanium grade Ti-6A1-4V ELI (Meets ASTM Standard F-136). #### ഗ് Intended Use of the Device The devices covered by this submission are abutments which are placed into a dental implant to provide support for a prosthetic reconstruction. The Atlantis Abutment is intended for use as an accessory to an endosseous implant to support a prosthetic device in a partially or completely edentulous patient. It is intended for use to support single and multiple tooth prosthesis, in the mandible or maxilla. The prosthesis can be cement retained to the abutment. The abutment screw is intended to secure the abutment to the endosseous implant. #### র্ত Basis for Substantial Equivalence The Atlantis™ Abutment in Zirconia is substantially equivalent in intended use, material, design and performance to the Zimmer Screw Vent Implant System (K011028) and Atlantis Components Inc. Abutment in Zirconia (K052070). {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal features an eagle with its wings spread, and the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. The seal is black and white and has a simple, clean design. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR 3 2006 Atlantis Components, Incorporated C/O Ms. Betsy A. Brown B.A. Brown & Associates 8944 Tamaroa Terrace Skokie, Illinois 60076 Re: K053450 Trade/Device Name: Atlantis™ Abutment for Zimmer Interface Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous dental implant abutment Regulatory Class: II Product Code: NHA Dated: February 10, 2006 Received: February 13, 2006 Dear Ms. Brown: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ ### Page 2 - Ms. Betsy A. Brown Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours. Snytie y. Michael Dms. Chiú Lin, Ph.D. Director Division of Anesthesiology, General Hospital , Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Pre-market Notification Page - 000227 ## Indications for Use 510(k) Number (if Known) Kos 3450 Device Name: Atlantis TM Abutment for Zimmer Interface Indication for Use: The Atlantis Abutment is intended for use as an accessory to an endosseous implant to support a prosthetic device in a partially or completely edentulous patient. It is intended for use to support single and multiple tooth prosthesis, in the mandible or maxilla. The prosthesis can be cement retained to the abutment. The abutment screw is intended to secure the abutment to the endosseous implant. This device is compatible with the following manufacturers' implant systems: Zimmer Dental, Nobel Biocare, 3i, Lifecore, Sterngold, Implamed, Innova and BioHorizons. Please note: This device may be used in an early load situation, but is dependent on the specific implant system and protocol used by the dental professional. Prescription Use X (Part 21 CFR 801 SubpartD) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) | Signature: | Sina Rury | |--------------------------------------------------------|-----------| | Concurrence of CDRH, Office of Device Evaluation (ODE) | | gy General Hospi K0534156
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%